The normal and cancer groups presented significantly different expression levels of BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, ERBB2, MSH2, PALB2, PTEN, and TP53 (Supplementary Fig. 6A). Here, TP53 is linked to cancer.